Pyrroloquinoline Quinone

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Pyrroloquinoline Quinone or PQQ occurs normally in human tissue and certain plants, and is available as a natural supplement.[1][2] PQQ is believed to induce mitochondrial biogenesis.[2]

Potential uses[edit | edit source]

No established uses, although it has antioxidant, anti-inflammatory and neuroprotective effects and may help with mitochondrion dysfunction and help modulate energy metabolism.[2]

Cusack Protocol[edit | edit source]

The Cusack Protocol, which was devised for Ehlers-Danlos syndrome involves using eight different supplements, including PQQ.[3][4]

Evidence[edit | edit source]

[1] No clinical trials of PQQ have involved ME/CFS patients.[2]

Risks and safety[edit | edit source]

Based on limited studies, PQQ appears to be safe, although this has not been confirmed in patients with ME/CFS.[2]

Costs and availability[edit | edit source]

PQQ is available over the counter.

Notable studies[edit | edit source]

  • 2018, Mitochondrial Dysfunction and Chronic Disease: Treatment with Membrane Lipid Replacement and Other Natural Supplements[2] - (Book chapter)
  • 2013, Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects[1] - (Full text)]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. 1.0 1.1 1.2 Harris, Calliandra B.; Winyoo, Chowanadisai; Mishchuk, Darya O.; Satre, Mike A.; Slupsky, Carolyn M.; Rucker, Robert B. (December 1, 2013). "Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects". The Journal of Nutritional Biochemistry. 24 (12): 2076–2084. doi:10.1016/j.jnutbio.2013.07.008. ISSN 0955-2863.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 Nicolson, Garth L.; Ferreira, Gonzalo; Settineri, Robert; Ellithorpe, Rita R.; Breeding, Paul; Ash, Michael E. (2018). "Mitochondrial Dysfunction and Chronic Disease: Treatment with Membrane Lipid Replacement and Other Natural Supplements". In Oliveira, Paulo J. (ed.). Mitochondrial Biology and Experimental Therapeutics. Cham: Springer. pp. 499–522. doi:10.1007/978-3-319-73344-9_22. ISBN 978-3-319-73344-9.
  3. Cusack, Deborah. "What Works?". EDS and Polysaccharides. Retrieved October 4, 2020.
  4. Ehlers-Danlos Support Wilmington (March 10, 2016). "Cusack Protocol (slides)". facebook.com.